Overview Dividends

(EL) Estee Lauder Companies - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5184391044

Skincare, Makeup, Fragrance, Haircare, Tools

EPS (Earnings per Share)

EPS (Earnings per Share) of EL over the last years for every Quarter: "2020-09": 1.44, "2020-12": 2.61, "2021-03": 1.62, "2021-06": 0.78, "2021-09": 1.89, "2021-12": 3.01, "2022-03": 1.9, "2022-06": 0.42, "2022-09": 1.37, "2022-12": 1.54, "2023-03": 0.47, "2023-06": 0.07, "2023-09": 0.11, "2023-12": 0.88, "2024-03": 0.97, "2024-06": 0.64, "2024-09": 0.14, "2024-12": 0.62, "2025-03": 0.65, "2025-06": 0.09, "2025-09": 0.32,
EPS Growth (3y CAGR): -43.52%
EPS Trend (3y Corr): -16.8%
Last SUE: 0.54σ
Qual. Beats: 0

Revenue

Revenue of EL over the last years for every Quarter: 2020-09: 3562, 2020-12: 4853, 2021-03: 3864, 2021-06: 3936, 2021-09: 4392, 2021-12: 5539, 2022-03: 4245, 2022-06: 3561, 2022-09: 3930, 2022-12: 4620, 2023-03: 3751, 2023-06: 3609, 2023-09: 3518, 2023-12: 4279, 2024-03: 3940, 2024-06: 3871, 2024-09: 3361, 2024-12: 4004, 2025-03: 3550, 2025-06: 3407, 2025-09: 3481,
Revenue Growth (3y CAGR): -9.78%
Revenue Trend (3y Corr): -54.4%
Last SUE: 0.05σ
Qual. Beats: 0
Risk via 10d forecast
Volatility 43.6%
Value at Risk 5%th 62.2%
Relative Tail Risk -13.18%
Reward TTM
Sharpe Ratio 0.87
Alpha 22.84
Character TTM
Hurst Exponent 0.423
Beta 1.349
Beta Downside 1.717
Drawdowns 3y
Max DD 81.40%
Mean DD 51.31%
Median DD 55.92%

Description: EL Estee Lauder Companies October 14, 2025

The Estée Lauder Companies Inc. (NYSE: EL) designs, manufactures, markets and sells a broad portfolio of prestige beauty products-including skin-care, makeup, fragrance and hair-care-through a multi-channel network of department stores, specialty retailers, e-commerce platforms, salons, spas and its own direct-to-consumer stores.

Its brand roster spans high-end labels such as La Mer, Jo Malone London, Tom Ford and Le Labo, alongside mass-prestige names like Clinique, M·A·C, The Ordinary and Aveda, giving the company exposure across price points and consumer segments.

Recent financials show EL generated $17.7 billion in net sales for FY 2023, with a 6 % year-over-year increase driven primarily by a 30 % jump in digital sales and strong growth in anti-aging skin-care. Adjusted EPS rose to $2.57 and gross margins held near 71 %, reflecting pricing power despite inflationary pressure on raw-material costs.

Key macro drivers include rising global demand for premium skin-care, especially in Asia-Pacific, and consumer willingness to pay a premium for sustainability-focused formulations-trends that have historically delivered a 4–5 % premium price premium for “green” product lines.

For a deeper quantitative breakdown of EL’s valuation metrics and scenario analysis, the ValueRay platform offers a useful toolkit.

EL Stock Overview

Market Cap in USD 32,404m
Sub-Industry Personal Care Products
IPO / Inception 1995-11-16
Return 12m vs S&P 500 22.3%
Analyst Rating 3.11 of 5

EL Dividends

Metric Value
Dividend Yield 1.99%
Yield on Cost 5y 0.78%
Yield CAGR 5y 11.83%
Payout Consistency 97.9%
Payout Ratio 83.3%

EL Growth Ratios

Metric Value
CAGR 3y -25.42%
CAGR/Max DD Calmar Ratio -0.31
CAGR/Mean DD Pain Ratio -0.50
Current Volume 3142.1k
Average Volume 3615k

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (-930.0m TTM) > 0 and > 6% of Revenue (6% = 866.5m TTM)
FCFTA 0.05 (>2.0%) and ΔFCFTA -0.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 11.29% (prev 11.19%; Δ 0.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.08 (>3.0%) and CFO 1.60b > Net Income -930.0m (YES >=105%, WARN >=100%)
Net Debt (7.20b) to EBITDA (451.0m) ratio: 15.97 <= 3.0 (WARN <= 3.5)
Current Ratio 1.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (363.3m) change vs 12m ago 1.03% (target <= -2.0% for YES)
Gross Margin 74.19% (prev 72.29%; Δ 1.90pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 71.06% (prev 72.48%; Δ -1.42pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -0.96 (EBITDA TTM 451.0m / Interest Expense TTM 398.0m) >= 6 (WARN >= 3)

Altman Z'' 3.09

(A) 0.08 = (Total Current Assets 6.71b - Total Current Liabilities 5.08b) / Total Assets 19.33b
(B) 0.60 = Retained Earnings (Balance) 11.59b / Total Assets 19.33b
(C) -0.02 = EBIT TTM -381.0m / Avg Total Assets 20.32b
(D) 0.68 = Book Value of Equity 10.46b / Total Liabilities 15.44b
Total Rating: 3.09 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 28.33

1. Piotroski 2.50pt = -2.50
2. FCF Yield 2.64% = 1.32
3. FCF Margin 7.24% = 1.81
4. Debt/Equity 2.42 = 0.12
5. Debt/Ebitda 15.97 = -2.50
6. ROIC - WACC (= -10.04)% = -12.50
7. RoE -22.87% = -2.50
8. Rev. Trend -54.39% = -4.08
9. EPS Trend -16.81% = -0.84

What is the price of EL shares?

As of November 19, 2025, the stock is trading at USD 88.06 with a total of 3,142,105 shares traded.
Over the past week, the price has changed by -3.06%, over one month by -14.10%, over three months by -2.58% and over the past year by +38.93%.

Is EL a buy, sell or hold?

Estee Lauder Companies has received a consensus analysts rating of 3.11. Therefor, it is recommend to hold EL.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 23
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the EL price?

Issuer Target Up/Down from current
Wallstreet Target Price 101.9 15.7%
Analysts Target Price 101.9 15.7%
ValueRay Target Price 78.2 -11.3%

EL Fundamental Data Overview November 17, 2025

Market Cap USD = 32.40b (32.40b USD * 1.0 USD.USD)
P/E Forward = 44.4444
P/S = 2.2431
P/B = 8.1688
P/EG = 1.7603
Beta = 1.174
Revenue TTM = 14.44b USD
EBIT TTM = -381.0m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 418.0m USD (from shortTermDebt, last quarter)
Debt = 9.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.20b USD (from netDebt column, last quarter)
Enterprise Value = 39.61b USD (32.40b + Debt 9.42b - CCE 2.22b)
Interest Coverage Ratio = -0.96 (Ebit TTM -381.0m / Interest Expense TTM 398.0m)
FCF Yield = 2.64% (FCF TTM 1.04b / Enterprise Value 39.61b)
FCF Margin = 7.24% (FCF TTM 1.04b / Revenue TTM 14.44b)
Net Margin = -6.44% (Net Income TTM -930.0m / Revenue TTM 14.44b)
Gross Margin = 74.19% ((Revenue TTM 14.44b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 73.37% (prev 71.97%)
Tobins Q-Ratio = 2.05 (Enterprise Value 39.61b / Total Assets 19.33b)
Interest Expense / Debt = 0.91% (Interest Expense 86.0m / Debt 9.42b)
Taxrate = 56.88% (62.0m / 109.0m)
NOPAT = -164.3m (EBIT -381.0m * (1 - 56.88%)) [loss with tax shield]
Current Ratio = 1.32 (Total Current Assets 6.71b / Total Current Liabilities 5.08b)
Debt / Equity = 2.42 (Debt 9.42b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 15.97 (Net Debt 7.20b / EBITDA 451.0m)
Debt / FCF = 6.89 (Net Debt 7.20b / FCF TTM 1.04b)
Total Stockholder Equity = 4.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.81% (Net Income -930.0m / Total Assets 19.33b)
RoE = -22.87% (Net Income TTM -930.0m / Total Stockholder Equity 4.07b)
RoCE = -3.35% (EBIT -381.0m / Capital Employed (Equity 4.07b + L.T.Debt 7.32b))
RoIC = -1.44% (negative operating profit) (NOPAT -164.3m / Invested Capital 11.37b)
WACC = 8.60% (E(32.40b)/V(41.83b) * Re(10.98%) + D(9.42b)/V(41.83b) * Rd(0.91%) * (1-Tc(0.57)))
Discount Rate = 10.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 58.48% ; FCFE base≈1.16b ; Y1≈761.7m ; Y5≈348.3m
Fair Price DCF = 18.58 (DCF Value 4.57b / Shares Outstanding 245.9m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -16.81 | EPS CAGR: -43.52% | SUE: 0.54 | # QB: 0
Revenue Correlation: -54.39 | Revenue CAGR: -9.78% | SUE: 0.05 | # QB: 0

Additional Sources for EL Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle